Bridge to Life Welcomes David Castiglioni as Chief Commercial Officer
Bridge to Life Ltd. is excited to announce the appointment of David Castiglioni as the new Chief Commercial Officer (CCO). With extensive experience in the healthcare and biotechnology sectors, Mr. Castiglioni is set to spearhead the company’s global commercial operations.
Focus on VitaSmart™ Hypothermic Oxygenated Perfusion System
In his new role, Mr. Castiglioni will focus on the U.S. launch of the innovative VitaSmart™ Hypothermic Oxygenated Perfusion System, aligning preparation efforts towards securing FDA clearance. The U.S. market stands as the largest for machine perfusion technology, underscoring the significance of this initiative.
David Castiglioni's Impressive Background
David Castiglioni offers nearly 30 years of leadership in the healthcare sector, with a strong focus on driving growth within medtech and biotechnology. His experience includes significant roles at Intuitive Surgical, where he played a crucial role in the expansion of the da Vinci surgical system. This experience has equipped him with the skills necessary to build high-performing teams and scale businesses in competitive environments.
Proven Track Record in Commercial Success
Having served as CCO at various innovative companies, including Hyperfine and MediGO, David has a history of developing successful go-to-market strategies. His expertise spans significant growth across regions including the U.S., Europe, and Asia-Pacific, making him an ideal fit for the challenges ahead.
Leadership Perspective on the Appointment
In light of this new appointment, Don Webber, President and CEO of Bridge to Life, expressed enthusiasm regarding Castiglioni's integration into the leadership team. He emphasized David's extensive knowledge of the commercial landscape and his ability to create powerful teams that respond to market dynamics.
Excitement for the Future
David Castiglioni expressed his excitement in joining Bridge to Life, noting the potential impact of the VitaSmart™ system in the transplant sector. He highlighted that his discussions with clinical professionals indicate that VitaSmart™ will significantly enhance the transplant ecosystem.
About Bridge to Life Ltd.
Bridge to Life Ltd. stands at the forefront of organ preservation, offering products such as Belzer UW®, EasiSlush®, and the VitaSmart™ system. Committed to innovation and quality, the company collaborates with premier transplant centers and organ procurement organizations globally, ensuring that its cutting-edge solutions are accessible to those in need.
VitaSmart™ Availability
The VitaSmart™ Hypothermic Oxygenated Perfusion System is currently CE Marked, making it available in various international markets while it awaits FDA clearance in the U.S. This positioning presents an enormous opportunity for the company to advance its holistic transplantation solutions.
Frequently Asked Questions
What is the role of David Castiglioni at Bridge to Life?
David Castiglioni has been appointed as Chief Commercial Officer, responsible for global commercial operations and the U.S. launch of VitaSmart™.
What is VitaSmart™?
VitaSmart™ is a Hypothermic Oxygenated Perfusion System aimed at improving organ preservation during transplantation.
How does Bridge to Life support transplant organizations?
Bridge to Life partners with leading transplant centers and organ procurement organizations to provide quality products and solutions focused on organ preservation.
What experience does David Castiglioni bring to his role?
David Castiglioni has nearly three decades of leadership experience in healthcare and medtech, including successful tenures at Intuitive Surgical and other innovative companies.
Is VitaSmart™ available in the U.S.?
Currently, VitaSmart™ is CE Marked and available in several markets outside of the U.S., with pending FDA clearance for U.S. distribution.
